Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: A multicenter prospective cohort study.
cerebral small vessel disease
cognitive impairment
functional outcome
prediction
stroke
Journal
Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
revised:
25
04
2022
received:
09
02
2022
accepted:
01
06
2022
medline:
17
4
2023
pubmed:
26
7
2022
entrez:
25
7
2022
Statut:
ppublish
Résumé
It remains unknown whether the global small vessel disease (SVD) burden predicts post-stroke outcomes. In a prospective multicenter study of 666 ischemic and hemorrhagic stroke patients, we quantified magnetic resonance imaging (MRI)-based SVD markers (lacunes, white matter hyperintensities, microbleeds, perivascular spaces) and explored associations with 6- and 12-month cognitive (battery of 15 neuropsychological tests) and functional (modified Rankin scale) outcomes. A global SVD score (range 0-4) was associated with cognitive impairment; worse performance in executive function, attention, language, and visuospatial ability; and worse functional outcome across a 12-month follow-up. Although the global SVD score did not improve prediction, individual SVD markers, assessed across their severity range, improved the calibration, discrimination, and reclassification of predictive models including demographic, clinical, and other imaging factors. SVD presence and severity are associated with worse cognitive and functional outcomes 12 months after stroke. Assessing SVD severity may aid prognostication for stroke patients. In a multi-center cohort, we explored associations of small vessel disease (SVD) burden with stroke outcomes. SVD burden associates with post-stroke cognitive and functional outcomes. A currently used score of SVD burden does not improve the prediction of poor outcomes. Assessing the severity of SVD lesions adds predictive value beyond known predictors. To add predictive value in assessing SVD in stroke patients, SVD burden scores should integrate lesion severity.
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1152-1163Informations de copyright
© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Références
Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 Study. Neuroepidemiology. 2015;45(3):161-176.
Hachinski V, Einhaupl K, Ganten D, et al. Preventing dementia by preventing stroke: the Berlin Manifesto. Alzheimers Dement. 2019;15(7):961-984.
Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8(8):741-754.
Pendlebury ST, Rothwell PM. Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248-258.
Sexton E, McLoughlin A, Williams DJ, et al. Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke. Eur Stroke J. 2019;4(2):160-171.
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006-1018.
Koton S, Pike JR, Johansen M, et al. Association of ischemic stroke incidence, severity, and recurrence with dementia in the atherosclerosis risk in communities cohort study. JAMA Neurol. 2022;79(3):271-280.
Fride Y, Adamit T, Maeir A, et al. What are the correlates of cognition and participation to return to work after first ever mild stroke? Top Stroke Rehabil. 2015;22(5):317-325.
Melkas S, Oksala NK, Jokinen H, et al. Poststroke dementia predicts poor survival in long-term follow-up: influence of prestroke cognitive decline and previous stroke. J Neurol Neurosurg Psychiatry. 2009;80(8):865-870.
Nys GM, van Zandvoort MJ, de Kort PL, et al. The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology. 2005;64(5):821-827.
Oksala NK, Jokinen H, Melkas S, et al. Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry. 2009;80(11):1230-1235.
Ganesh A, Luengo-Fernandez R, Wharton RM, et al. Time course of evolution of disability and cause-specific mortality after ischemic stroke: implications for trial design. J Am Heart Assoc. 2017;6(6):e005788.
Sudlow CL, Warlow CP, Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28(3):491-499.
Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632-1644.
Iadecola C, Duering M, Hachinski V, et al. Vascular cognitive impairment and dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(25):3326-3344.
Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684-696.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822-838.
Wen W, Sachdev PS, Extent and distribution of white matter hyperintensities in stroke patients: the Sydney Stroke Study. Stroke. 2004;35(12):2813-2819.
Debette S, Schilling S, Duperron MG, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 2019;76(1):81-94.
Georgakis MK, Duering M, Wardlaw JM, Dichgans M. WMH and long-term outcomes in ischemic stroke: a systematic review and meta-analysis. Neurology. 2019;92(12):e1298-e1308.
Charidimou A, Turc G, Oppenheim C, et al. Microbleeds, cerebral hemorrhage, and functional outcome after stroke thrombolysis. Stroke. 2017;48(8):2084-2090.
Pasi M, Sugita L, Xiong L, et al. Association of cerebral small vessel disease and cognitive decline after intracerebral hemorrhage. Neurology. 2021;96(2):e182-e192.
Yilmaz P, Ikram MK, Niessen WJ, Ikram MA, Vernooij MW. Practical small vessel disease score relates to stroke, dementia, and death. Stroke. 2018;49(12):2857-2865.
Jokinen H, Koikkalainen J, Laakso HM, et al. Global burden of small vessel disease-related brain changes on MRI predicts cognitive and functional decline. Stroke. 2020;51(1):170-178.
Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228-1234.
Staals J, Booth T, Morris Z, et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging. 2015;36(10):2806-2811.
Amin Al Olama A, Wason JMS, Tuladhar AM, et al. Simple MRI score aids prediction of dementia in cerebral small vessel disease. Neurology. 2020;94(12):e1294-e1302.
Zhi N, Zhang L, Wang Y, et al. Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke. Aging (Albany NY). 2021;13(7):9510-9521.
Arba F, Inzitari D, Ali M, et al. Small vessel disease and clinical outcomes after IV rt-PA treatment. Acta Neurol Scand. 2017;136(1):72-77.
Liang Y, Chen YK, Liu YL, et al. Cerebral small vessel disease burden is associated with accelerated poststroke cognitive decline: a 1-year follow-up study. J Geriatr Psychiatry Neurol. 2019;32(6):336-343.
Coutureau J, Asselineau J, Perez P, et al. Cerebral small vessel disease MRI features do not improve the prediction of stroke outcome. Neurology. 2021;96(4):e527-e537.
Wollenweber FA, Zietemann V, Rominger A, et al. The Determinants of Dementia After Stroke (DEDEMAS) Study: protocol and pilot data. Int J Stroke. 2014;9(3):387-392.
Zietemann V, Georgakis MK, Dondaine T, et al. Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke. Neurology. 2018;91(20):e1838-e1850.
Jorm AF, Korten AE. Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry. 1988;152:209-213.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, immerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351-356.
Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450-454.
Maclullich AM, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry. 2004;75(11):1519-1523.
Knopman DS, Beiser A, Machulda MM, et al. Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging. Neurology. 2015;85(19):1712-1721.
Palmcrantz S, Wall A, Vreede KS, et al. Impact of intensive gait training with and without electromechanical assistance in the chronic phase after stroke-A multi-arm randomized controlled trial with a 6 and 12 months follow up. Front Neurosci. 2021;15:660726.
Mahoney FI, Barthel DW. Functional evaluatoin: the Barthel Index. Md State Med J. 1965;14:61-65.
Synhaeve NE, Schaapsmeerders P, Arntz RM, et al. Cognitive performance and poor long-term functional outcome after young stroke. Neurology. 2015;85(9):776-782.
Maldaner N, Sosnova M, Sarnthein J, Bozinov O, Regli L, tienen MN. Predicting functional impairment in patients with chronic subdural hematoma treated with burr hole Trepanation-The FIT-score. Clin Neurol Neurosurg. 2019;182:142-147.
Jampathong N, Laopaiboon M, Rattanakanokchai S, Pattanittum P. Prognostic models for complete recovery in ischemic stroke: a systematic review and meta-analysis. BMC Neurol. 2018;18(1):26.
Burton L, Tyson SF. Screening for cognitive impairment after stroke: a systematic review of psychometric properties and clinical utility. J Rehabil Med. 2015;47(3):193-203.
Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users' guides to the medical literature. JAMA. 2017;318(14):1377-1384.
Austin PC, Steyerberg EW. The Integrated Calibration Index (ICI) and related metrics for quantifying the calibration of logistic regression models. Stat Med. 2019;38(21):4051-4065.
Pencina MJ, D'Agostino RB, Sr, D'Agostino RB, Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172.
Weaver NA, Kuijf HJ, Aben HP, et al. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol. 2021;20(6):448-459.
Jickling GC, Chen C. Rating total cerebral small-vessel disease: does it add up? Neurology. 2014;83(14):1224-1225.
SPRINT MIND Investigators for the SPRINT Research Group, Nasrallah IM, Pajewski NM, et al. Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA. 2019;322(6):524-534.
SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553-561.